Adenosine Receptors in Health and Disease

Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a n...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Wilson, Constance N. (Editor), Mustafa, S. Jamal. (Editor)
Format: Electronic
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg, 2009.
Series:Handbook of Experimental Pharmacology, 193
Subjects:
Online Access:View fulltext via EzAccess
LEADER 02550nam a22004695i 4500
001 6661
003 DE-He213
005 20130725195039.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 # # |a 9783540896159  |9 978-3-540-89615-9 
024 7 # |a 10.1007/978-3-540-89615-9  |2 doi 
050 # 4 |a RM1-950 
072 # 7 |a MMG  |2 bicssc 
072 # 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
100 1 # |a Wilson, Constance N.  |e editor. 
245 1 0 |a Adenosine Receptors in Health and Disease  |c edited by Constance N. Wilson, S. Jamal Mustafa.  |h [electronic resource] / 
264 # 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2009. 
300 # # |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
490 1 # |a Handbook of Experimental Pharmacology,  |v 193  |x 0171-2004 ; 
520 # # |a Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a number of different cell types and in a number of different organ systems they play important roles in specific diseases, including asthma, rheumatoid arthritis, Parkinson s disease, multiple sclerosis, Alzheimer s disease, heart disease, stroke, cancer, sepsis, and obesity. As a result of intense investigations into understanding the molecular structures and pharmacology of these proteins, new molecules have been synthesized that have high specificity for these proteins and are now entering clinical trials. These molecules will define the next new classes of drugs for a number of diseases with unmet medical needs. 
650 # 0 |a Medicine. 
650 # 0 |a Human physiology. 
650 # 0 |a Toxicology. 
650 # 0 |a Cytology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Human Physiology. 
650 2 4 |a Cell Biology. 
700 1 # |a Mustafa, S. Jamal.  |e editor. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540896142 
830 # 0 |a Handbook of Experimental Pharmacology,  |v 193  |x 0171-2004 ; 
856 4 0 |z View fulltext via EzAccess  |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-540-89615-9 
912 # # |a ZDB-2-SBL 
950 # # |a Biomedical and Life Sciences (Springer-11642)